4//SEC Filing
Schaeffer Orlov S Nicole 4
Accession 0001628280-25-052361
CIK 0001104506other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:12 PM ET
Size
13.9 KB
Accession
0001628280-25-052361
Insider Transaction Report
Form 4
INSMED IncINSM
Schaeffer Orlov S Nicole
Chief People Strategy Officer
Transactions
- Sale
Common Stock
2025-11-12$192.45/sh−4,078$784,811→ 62,383 total - Sale
Common Stock
2025-11-12$193.64/sh−6,575$1,273,183→ 55,808 total - Sale
Common Stock
2025-11-12$194.44/sh−19,183$3,729,943→ 36,625 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-12−30,000→ 15,760 totalExercise: $26.46Exp: 2031-05-12→ Common Stock (30,000 underlying) - Sale
Common Stock
2025-11-12$195.88/sh−164$32,124→ 36,461 total - Exercise/Conversion
Common Stock
2025-11-12$26.46/sh+30,000$793,800→ 66,461 total
Footnotes (5)
- [F1]This is the weighted average sales price representing 4,078 shares sold at prices ranging from $192.00 to $192.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F2]This is the weighted average sales price representing 6,575 shares sold at prices ranging from $193.02 to $194.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F3]This is the weighted average sales price representing 19,183 shares sold at prices ranging from $194.02 to $194.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F4]This is the weighted average sales price representing 164 shares sold at prices ranging from $195.42 to $195.96 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F5]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Documents
Issuer
INSMED Inc
CIK 0001104506
Entity typeother
Related Parties
1- filerCIK 0001401017
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:12 PM ET
- Size
- 13.9 KB